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Abstract
In addition to protein coding genes a substantial proportion of mammalian genomes are transcribed. However, most
transcriptome studies investigate steady-state mRNA levels, ignoring a considerable fraction of the transcribed genome. In
addition, steady-state mRNA levels are influenced by both transcriptional and posttranscriptional mechanisms, and thus do
not provide a clear picture of transcriptional output. Here, using deep sequencing of nuclear RNAs (nucRNA-Seq) in parallel
with chromatin immunoprecipitation sequencing (ChIP-Seq) of active RNA polymerase II, we compared the nuclear
transcriptome of mouse anemic spleen erythroid cells with polymerase occupancy on a genome-wide scale. We
demonstrate that unspliced transcripts quantified by nucRNA-seq correlate with primary transcript frequencies measured by
RNA FISH, but differ from steady-state mRNA levels measured by poly(A)-enriched RNA-seq. Highly expressed protein
coding genes showed good correlation between RNAPII occupancy and transcriptional output; however, genome-wide we
observed a poor correlation between transcriptional output and RNAPII association. This poor correlation is due to
intergenic regions associated with RNAPII which correspond with transcription factor bound regulatory regions and a group
of stable, nuclear-retained long non-coding transcripts. In conclusion, sequencing the nuclear transcriptome provides an
opportunity to investigate the transcriptional landscape in a given cell type through quantification of unspliced primary
transcripts and the identification of nuclear-retained long non-coding RNAs.
Citation: Mitchell JA, Clay I, Umlauf D, Chen C-y, Moir CA, et al. (2012) Nuclear RNA Sequencing of the Mouse Erythroid Cell Transcriptome. PLoS ONE 7(11):
e49274. doi:10.1371/journal.pone.0049274
Editor: Ju¨rg Ba¨hler, University College London, United Kingdom
Received July 18, 2012; Accepted October 8, 2012; Published November 29, 2012
Copyright:  2012 Mitchell et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Medical Research Council and the Biotechnology and Biological Sciences Research Council, UK (operating grants held
by PF) and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant held by JAM). DU was supported by an EMBO fellowship, and CYC
was supported in part by an Ontario Graduate Scholarship. The ENCODE project is funded by the National Human Genome Research Institute, National Institutes
of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ja.mitchell@utoronto.ca
. These authors contributed equally to this work.
Introduction
While the full complexity of mammalian transcriptomes has yet
to be characterized, it is clear that far more transcription occurs
than can be accounted for by protein-coding genes alone [1,2,3].
Transcription of both coding and non-coding RNA (ncRNA) by
the eukaryotic RNA polymerase II (RNAPII) complex requires the
co-operation of numerous factors to control polymerase recruit-
ment and promoter escape, transcriptional initiation, elongation
and termination (reviewed in [4]). Each of these distinct stages
represents a potential point at which gene expression can be
regulated. For example, several studies have revealed that RNAPII
is present in higher levels at the 59 end of many eukaryotic genes
compared to the downstream regions of the gene [5,6,7,8], leading
to the idea of promoter-proximal ‘pausing’ or ‘stalling’ of the
transcription complex. Using a global nuclear run-on-sequencing
assay (GRO-Seq) stalled RNAPII associated with the 59 end of
genes was found to be engaged in the production of sense
transcripts downstream of the promoter as well as antisense RNA
upstream of the promoter [9]. Such transcription may play an
important role in transcriptional interference and bystander effects
which have been reported for mammalian genomes
[10,11,12,13,14].
A study of global genome folding revealed that the active and
inactive portions of the genome are individually segregated [15]
consistent with compartmentalisation of transcription in mamma-
lian nuclei. On a smaller scale, the three-dimensional folding of
chromatin in the nucleus is an important factor in regulating gene
expression in a tissue-specific manner [16]. In the developmentally
regulated murine b-globin locus (Hbb), tissue-specific chromatin
loops form between expressed genes and the locus control region
(LCR) located approximately 50 kb upstream [17,18,19]. Similar
chromatin loops have now been identified and implicated in the
regulation of numerous other gene loci, including: the a-globin
locus (Hba), Th2, MHC, IgH, Igk, HoxB1, CFTR, and olfactory
receptor genes [20–27].
The multitude of processes that influence regulation of
transcription impose challenges on the analysis of the transcrip-
tome. In this study we analyse transcriptional output and RNAPII
association in adult mouse anemic spleen erythroid cells by
generating genome-wide nuclear RNA and RNAPII chromatin-
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association [28] profiles. We demonstrate that nucRNA-Seq
provides a representative description of nascent transcription at
erythroid-expressed genes. Through comparative analyses, we
show that high and low transcriptional output correlate with
particular patterns of polymerase occupancy. With integration of
publicly available data, we identify putative regulatory regions and
ncRNAs that are stably retained in the nucleus of erythroid cells.
Results
Nuclear transcriptome generation and validation
RNA-Seq libraries are usually generated from poly(A) positive
RNA isolated from intact cells and thus reflect the steady-state
levels of mRNA present in the cell population [29]. As we wanted
to investigate nascent transcriptional output, we isolated intact
nuclei, purified total nuclear RNA and used random primers for
reverse transcription (RT) to generate cDNA representative of
nuclear RNA (Figure 1). Initial quantitative real-time RT-PCR
(RT-qPCR) quality control performed on nuclear RNA confirmed
that Hba, Slc4a1 and Uros, known erythroid-expressed genes were
represented, while a non-transcribed region of the IgH locus
(VH16) was not detected (Figure 2A). To assess the level of
enrichment for nuclear RNA species, we performed RT-qPCR on
the nuclear and cytoplasmic RNA fractions using exonic and
intronic primer pairs. As expected, we found exonic sequences
were distributed between the two fractions while intronic
sequences were found almost exclusively in the nuclear fraction
(Figure 2B). Furthermore, we found the Air long non-coding RNA
almost exclusively in the nuclear fraction in agreement with the
finding that Air RNA is retained in the nucleus [30,31].
We generated a nuclear transcriptome for adult mouse anemic
spleen erythroid cells by sequencing our validated nuclear RNA
(nucRNA-Seq) using the Illumina paired-end sequencing protocol
(Figure 1). We obtained greater than ten million aligned sequence
pairs from three replicate nucRNA double-stranded cDNA
libraries. As expected, we observed high nucRNA-Seq coverage
(sequence representation) at strongly expressed erythroid-specific
genes, including the adult a-like globin (Hba-a1, Hba-a2) and b-like
globin genes (Hbb-b1 and Hbb-b2), the erythrocyte membrane
protein band 3 (Scl4a1) and hydroxymethylbilane synthase (Hmbs,
selected genes shown in Figure 2C). More moderately expressed
genes such as the heme pathway member Uros (uroporphyrinogen
III synthase) had lower coverage, while the silent, brain-specific
gene Nefm was not enriched above the surrounding intergenic
background coverage.
We calculated the number of reads per kilobase of gene length
per million mapped reads (RPKM) at mouse Ensembl genes for
our three replicate nucRNA-Seq libraries (Table S1) [32]. A
comparison of RPKM values in our three biological replicate
libraries indicated that relative transcript abundance was repro-
ducible between samples (Spearman’s rho .0.8, Figure S1). In
addition we compared the observed coverage and reproducibility
for 48 randomly selected nucRNA-Seq enriched regions to RNA
levels in two independent nuclear RNA preparations by RT-
qPCR. We observed a significant association between RT-qPCR
results and nucRNA-Seq coverage (Figure S2). Considering the
biological replicate nucRNA-Seq libraries individually, we ob-
served highly reproducible coverage for these regions, however as
the association with our RT-qPCR data was seen to be stronger
for the combined nucRNA-Seq data than any of the 3 individual
experiments, the nucRNA-Seq data was considered as one dataset
for the remaining analyses.
NucRNA-Seq coverage reflects primary transcription
levels
To confirm that nucRNA-Seq is indicative of raw transcrip-
tional output, we compared exonic and intronic coverage to
Figure 1. Outline of the experimental strategy. The nuclear
transcriptome as well as RNAPII-associated genomic sequences of
actively transcribing cells are analysed by nucRNA-Seq and RNAPII ChIP-
Seq, respectively, as indicated. Top: schematic representation of
transcription in the nucleus: four transcribing RNAPII complexes
depicted as green shapes are associated with two chromatin fibres,
DNA shown in red and blue, respectively; a third chromatin region,
which is not being transcribed, is shown with DNA in black; histone
complexes are yellow circles, nascent transcripts are shown as thin wavy
lines, colours corresponding to chromatin. The nucRNA-Seq procedure
is outlined on the left; purified nuclear RNA from the two transcribed
regions is shown as wavy or straight lines colour-coded as above, DNA
is depicted as thicker lines, random primers are black arrows, a putative
genomic region with aligned Illumina paired-end (PE) tags signifies
nucRNA-Seq data. The RNAPII ChIP-Seq procedure is outlined on the
right; immunoprecipitated RNAPII-associated nucleosomes are depicted
and colour-coded as above with cross-links as yellow crosses, anti-
RNAPII antibodies are shown as red Y shapes, purified DNA is
represented by thick lines, a putative genomic region with PE tags
signifies RNAPII ChIP-Seq data.
doi:10.1371/journal.pone.0049274.g001
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demonstrate that the sequence data was derived mainly from
unprocessed, immature transcripts. In a hypothetical, completely
unspliced transcript, we would expect the mean exonic and
intronic coverage depths to match, with removal of introns
resulting in an exonic bias (high coverage of exons relative to
introns). As a proof of concept for this hypothesis, we first
compared our nucRNA-Seq dataset to a poly(A) enriched RNA-
Seq dataset from a similar cell type. The G1E cells are committed
erythroid progenitor cells derived from Gata1-null mouse ES cells
[33]. These cells undergo terminal differentiation upon restoration
of Gata1 expression. This is achieved upon treatment with estradiol
(E2) in the G1E-ER4 subline which contains an estrogen-activated
Gata1-estrogen receptor transgene [34,35]. We initially compared
the exonic and intronic coverage in our nucRNA-Seq data with
the intronic and exonic coverage in G1E and G1E-ER4+E2 RNA-
Seq datasets [36]. As expected the G1E and G1E-ER4+E2 RNA-
Seq mapped mainly to exons (85% and 95% exonic respectively)
however our nucRNA-Seq library showed a strong bias toward
intronic reads as introns are generally much larger than exons
(36% exonic).
To provide further evidence that we were capturing primary
transcription, we next investigated the exonic and intronic
coverage in more detail in our nucRNA-Seq library. As true
sequence enrichment can be masked by bias introduced during
alignment against a reference genome [37,38], sequence coverage
was normalised relative to a sequenced genomic input DNA
library in order to assess true biological enrichment (Figure S3).
Unless otherwise stated, all subsequent data is given as fold
enrichment over input. Average nucRNA-Seq coverage at
annotated genes shows a significant correlation between exonic
and intronic regions (Figure 3A, rs = 0.850, 95% CI [0.844, 0.855],
p,0.01). Dividing each gene into 59, body, and 39 thirds, we
observed the association between exonic and intronic coverage
levels to increase in a 59 to 39 direction (59 rs = 0.712, 95% CI
Figure 2. Validation of nuclear RNA material and sequence coverage at selected genes. A) Quantitative PCR validation of transcript
representation for cDNA samples used for construction of nucRNA-Seq libraries (F1.2, F2.2 and F3.2, F4 is the RT- sample for F1.2) relative to the
housekeeping gene Gapdh was confirmed. Error bars depict one standard deviation calculated from three technical replicates. B) Quantitative PCR
validation of nuclear/cytoplasmic fractionation. Nuclear and cytoplasmic RNA was reverse transcribed using random primers to generate cDNA.
Absolute quantities of specific gene regions were determined in these samples by real-time PCR using genomic DNA standard curves. The relative
amount in each fraction per ng of RNA is depicted. We found exonic sequences were distributed between the nuclear and cytoplasmic fractions while
intronic sequences were found almost exclusively in the nuclear fraction. Furthermore, we found Air ncRNA almost exclusively in the nuclear fraction.
C) Shown are selected genes: erythroid-specific (Hba cluster, Hmbs, Uros), ubiquitous (H2afx) and a brain-specific gene, Nefm that is not expressed in
erythroid cells. Nuclear RNA sequence coverage is shown in blue. All genomic regions are depicted from centromere to telomere and the 59 end of
the gene is marked by the gene name.
doi:10.1371/journal.pone.0049274.g002
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[0.702, 0.721], p,0.01; body rs = 0.726, 95% CI [0.716, 0.734],
p,0.01; 39 rs = 0.788, 95% CI [0.781, 0.794], p,0.01), with 59
regions displaying a slight exonic bias (Figure 3A). Both of these
observations are consistent with current models of co-transcrip-
tional splicing [39] and with the conclusion that our nucRNA-Seq
coverage represents nascent transcription.
In addition, we compared the average nucRNA-Seq coverage
depth at 19 erythroid-expressed genes to the transcription
frequency determined by RNA fluorescence in-situ hybridisation
(FISH, Figure 3B, 3C) [40]. We used intronic probes to determine
the number of cells in the population with actively transcribing
alleles for any given gene. Transcription frequency was calculated
as the percentage of expressed alleles in the population, i.e. those
with detectable signals (Table S2). We found a significant log-
linear association between the transcription frequency determined
by RNA FISH and the maximum nucRNA coverage depth
(rs = 0.820, 95% CI [0.582, 0.928], p,0.01). This indicates that
nucRNA quantity is reflective of the frequency at which primary
transcription occurs in the cell population for erythroid-expressed
protein-coding genes (Figure 3B, 3C).
Taken together, our results indicate that nucRNA-Seq data
reflect in vivo primary transcript levels. We were interested to
investigate how different the relative levels of primary transcripts
were compared to total poly(A) positive mRNA. To do this we
compared RPKM coverage over the first exon in our nucRNA-
Seq data to RPKM coverage over the first exon in the G1E and
G1E-ER4+E2 RNA-Seq data (Figure S4). While the correlation
between the two RNA-Seq libraries was quite high (Spearman’s
rho= 0.88) correlation between nucRNA-Seq and RNA-Seq data
was low (Spearman’s rho= 0.25 and 0.30). Specifically we noted
that coverage at exon 1 was more often overrepresented in the
nucRNA-Seq data compared to the RNA-Seq data.
RNAPII ChIP-Seq generation and validation
As our nucRNA-Seq data correlated with in vivo primary
transcript levels we next wanted to investigate the relationship
between nucRNA levels and RNAPII association throughout the
genome. We performed chromatin immunoprecipitation (ChIP) of
the large subunit of the polymerase complex (RPB1) phosphor-
ylated at serine 5 (S5) of the carboxy-terminal domain (CTD). The
RPB1 CTD consists of a heptapeptide repeat of the consensus
sequence YSPTSPS [41] which is unphosphorylated during initial
recruitment to promoters as part of a pre-initiation complex. In
promoter-proximal regions the CTD is phosphorylated on S5
(S5P) which leads to recruitment of the capping enzyme
[42,43,44,45]. The S5P modification of the CTD acquired at
the initiation phase of transcription persists throughout the
transcription cycle as this polymerase form has been found
associated throughout the body of transcribed and poised genes
[46,47,48,49]. In our ChIP experiments we therefore used an
antibody that detects the S5 phosphorylated form of RNAPII. As
part of our initial quality control we assayed fold enrichment in the
RNAPII ChIP sample compared to the input sample by qPCR at
a subset of expressed and non-expressed genes. As expected we
found high levels of enrichment at erythroid-expressed genes and
no enrichment at silent genes (Figure S5).
Sequencing of RNAPII ChIP (ChIP-Seq) using the Illumina
paired-end sequencing protocol produced more than six million
paired, aligned 36 bp sequences from each of the immuno-purified
and genomic input fractions. As expected, and similar to the
nucRNA-Seq coverage, RNAPII was associated with erythroid-
expressed genes (Figure S6). As for nucRNA-Seq, we normalised
the RNAPII ChIP-Seq to the sequenced input in order to assess
true biological enrichment (Figure S3) [37]. At highly expressed
genes (e.g. Slc4a1, Figure S6) we found sequence enrichment in the
RNAPII ChIP-Seq data throughout the entire transcription unit.
This enrichment was also identified throughout the Slc4a1
transcription unit by qPCR (Figure S5).
In order to further validate observed coverage, fold enrichment
over input was assessed by qPCR for 3 independent ChIP
experiments and compared to our sequencing data at the same 48
randomly selected regions used to validate the nucRNA-Seq
coverage. We observed a significant association between the fold
enrichment assessed by qPCR and the RNAPII ChIP-Seq data,
both for maximum coverage depth in the tested amplicon
(rs = 0.683, 95% CI [0.489, 0.812], p,0.01) and for average
coverage depth (rs = 0.668, 95% CI [0.477, 0.799], p,0.01)
(Figure S7).
Figure 3. Sequencing nuclear RNA reflects primary transcrip-
tion at erythroid-expressed genes. A) Exonic vs intronic coverage
for annotated genes in the 59 (red), body (orange) and 39 (yellow)
regions by splitting each gene into equal thirds. B) Examples of RNA
FISH signals for Ank1 and Gypa shown in green, Hbb-b1 is shown in red,
nuclear DAPI staining is shown in blue, scale bar = 1 mm. C)
Transcription frequency determined by RNA FISH compared to gene
coverage in nucRNA-Seq data. We found a significant log-linear
association between the transcription frequency determined by RNA
FISH and the maximum nucRNA coverage depth (rs = 0.820, 95% CI
[0.582, 0.928], p,0.01).
doi:10.1371/journal.pone.0049274.g003
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Comparative analysis of nucRNA-Seq and RNAPII ChIP-
Seq
We next investigated the relationship between RNAPII
association examined by RNAPII ChIP-Seq and transcriptional
output assayed by nucRNA-Seq. Using a 10 kb window, we
compared RNAPII ChIP-Seq and nucRNA-Seq coverage depth
throughout the genome. We identified the highly enriched outliers
in each dataset using the boxplot method (thresholds set as
Q3+(1.56IQR), where Q3 is the upper quartile limit and IQR the
interquartile range). Using these thresholds we defined four classes
of genomic sequences in our data; regions that were highly
RNAPII-bound and transcribed (BT), bound by RNAPII but not
highly transcribed (B), transcribed but not highly RNAPII-
associated (T), and regions that were not highly RNAPII-
associated or transcribed (loBT, Figure 4A). Regions of the
genome falling into the BT and T categories frequently overlapped
Ensembl genes (75 and 94% respectively). In contrast, genomic
regions in the B class were less frequently associated with genic
regions, with only 26.6% of the regions in this class overlapping
with an Ensembl gene. In further data analysis we investigated
RNAPII association and transcriptional output at the genic and
intergenic regions of the genome separately.
RNAPII association and nascent transcription at
annotated genes
To explore the relationship between polymerase association and
nascent transcription for genic regions, we re-defined the BT, B,
T, and loBT classes in our data based on coverage of all Ensembl
genes (NCBIM37, Figure 4B) rather than 10 kb windows. We
identified 369 genes in the B category, 372 in the T and 191 genes
in the BT categories, with the remainder (30480, genes #300 bp
removed) showing lower levels of both polymerase association and
transcription (loBT). These observations are consistent with
current models which show very highly expressed genes to be in
the minority [6,7,9].
Next we calculated the ratio of nucRNA-Seq: RNAPII ChIP-
Seq maximum coverage depth as a measure of polymerase
transcription efficiency. BT genes display a more efficient ratio of
0.936 compared to 0.394 for loBT genes (5% trimmed mean for
each category) suggesting that the observed differences in
transcriptional output are not simply explained by different levels
of RNAPII association. Instead, it appears that polymerase
associated with BT genes is producing RNA more efficiently.
The T group displays the most efficient average nucRNA-Seq:
RNAPII ChIP-Seq ratio of 12.7.
To probe whether there were any functional relationships
behind the differences we observed in transcriptional behaviour,
we compared the Gene Ontology (GO) term enrichments between
the BT, T and B groups using the DAVID (Database for
Annotation, Visualization and Integrated Discovery, Table S3)
[50,51]. As expected, BT was enriched in highly expressed genes
and significantly enriched in erythroid functional categories as well
as DNA replication and DNA packaging GO terms. Anemic
spleen cells are rapidly dividing and would therefore require the
expression of genes associated with DNA replication. The T
category was significantly enriched in translation-related terms
including; ribonucleoprotein complex and ribosomal proteins. The
ribosomal protein genes in the T group may represent those with
increased RNA stability as ribosomal proteins are tightly regulated
both transcriptionally and post-transcriptionally to balance the
production of ribosomal components [52,53]. We also identified
nucRNA coverage at the genes encoding Terc (vertebrate
telomerase RNA), small nucleolar RNAs, signal recognition
particle RNAs, micro RNAs, and small Cajal body-specific RNAs
in the T group of genes suggesting this group is enriched for stable
functional and structural RNAs. We later use this signature to
identify intergenic regions encoding stable nuclear-retained
transcripts (described below). Also included in this group were
rRNAs and 7SK RNAs, which are transcribed by RNAPI and
RNAPIII respectively and are therefore not expected to associate
with RNAPII. B genes seem to be involved in stress responses
(though the enrichments were not significant following multiple
testing correction) and housekeeping functions (cell cycle, trans-
lation), which may point to ‘‘poising’’ of certain genes in readiness
for anticipated functions.
Figure 4. Comparison between RNAPII ChIP-Seq and nucle-
arRNA-Seq coverage. A) RNAPII vs nucRNA scores were calculated as
the maximum coverage depth within non-overlapping 10 kb windows,
normalised to the genomic input score. Threshold values for identifying
highly enriched regions were calculated using the boxplot method
(thresholds set as Q3+(1.56IQR), where Q3 is the upper quartile limit
and IQR the interquartile range) and are represented as black bars.
Windows containing an annotated gene are depicted as black circles,
windows lacking an annotated gene are depicted as red circles. Regions
were classed as either being highly RNAPII-bound and transcribed (BT);
highly transcribed, but with low RNAPII binding (T); or highly bound,
but not highly transcribed (B); low levels of both RNAPII association and
transcription (loBT). B) Scores were calculated for annotated genes only,
as described above.
doi:10.1371/journal.pone.0049274.g004
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As the GO analysis of the B category highlighted stress-response
genes, including heat shock genes which are known to be poised
for activation with polymerase stalled in the promoter-proximal
region [54,55], we calculated ‘‘stalling indices’’ for all annotated
genes by identifying peaks of RNAPII in the promoter-proximal
region [6,8,9,56]. Similar to the work of Zeitlinger et al [8], we
calculated the stalling index as the ratio of the maximum
promoter-proximal (transcription start site, TSS 6300 bp) signal
and the mean body signal, with a high ratio indicating ‘‘stalling’’.
Similar to previous findings [6,8] we found a trend for genes with
high promoter-proximal RNAPII peaks to have significantly lower
levels of nucRNA coverage (p,0.001, Jonckheere-Terpstra test,
Figure 5A). In fact, our data revealed an inverse correlation
between total RNAPII coverage and promoter-proximal RNAPII
peaks with the most highly RNAPII-associated genes having low
stalling indices. This fits with our observation that the most highly
expressed erythroid-specific genes (for example Hba and Slc4a1
Figures S5 and S6) generally contained RNAPII associated
throughout the entire transcription unit.
We also observed similar RNAPII peaks at the 39 end of selected
genes. We applied the same formula to calculate a ‘‘39 end stalling
index’’ for all annotated genes. Similar to the results for promoter-
proximal RNAPII peaks, we found a significant trend for genes
with high 39 end stalling indices to have lower levels of nucRNA
and RNAPII coverage in the gene body (p,0.001, Jonckheere-
Terpstra test, Figure 5B). To further dissect patterns of occupancy,
we compared promoter-proximal and 39 end RNAPII peaks,
identifying 300 genes with promoter, 300 genes with 39 end, and
60 genes with both promoter and 39 end RNAPII peaks
(thresholds set at the 95th percentile, Figures S8 and S9, Table
S4). We observed that the ‘‘double RNAPII peak’’ genes have less
polymerase in the body than other categories, but show equal if
not higher levels of RNA compared to other categories.
Examining the relationship between RNA and polymerase (only
considering the body of the gene to avoid the identified RNAPII
peaks at the 59 and 39 ends) we found that the double RNAPII
peak group produces more RNA per polymerase than the other
categories, with the ratio of RNA to polymerase being significantly
higher (p,0.0001, Kruskal-Wallace ANOVA, Figure 5C). We
conclude that transcription of a gene is clearly not a simple case of
RNA production following polymerase binding, as patterns of
RNAPII occupancy can correlate with transcription negatively (in
the case of ‘‘stalling’’ at either end), or positively (in the case of the
double RNAPII peak genes).
Intergenic RNAPII is associated with regulatory regions
As previously mentioned, we found that intergenic regions of
the genome tended to be associated with RNAPII in the absence of
nuclear RNA (B group, Figure 4A). Previous studies have found
that RNAPII in intergenic regions is associated with enhancer
features [57,58]. One of the most highly RNAPII-bound
intergenic regions is located upstream of the Hbb genes and
overlaps DNase I hypersensitive sites (HS) of the locus control
region (LCR, Figure 6A). The Hbb LCR is a well characterized
enhancer, required for high-level b-globin gene expression and has
been shown to be in close physical proximity with the active Hbb
genes, forming a chromatin loop [17,19,59]. In erythroid cells the
HS of the Hbb LCR are bound by several transcription factors as
well as RNAPII [35,60,61,62,63]. We observed very little
nucRNA in the LCR region suggesting the associated polymerase
is transcribing only at very low levels compared to transcription at
expressed genes [64].
Taking the Hbb LCR as a prototypical example, we investigated
other enhancer features at the regions associated with RNAPII but
Figure 5. RNAPII peaks are associated with both the promoter
and the 39 end of genes. A) Promoter-proximal (6300 bp) stalling
index plotted against RNAPII and nucRNA coverage at annotated genes.
B) 39 end (6300 bp) stalling index plotted against RNAPII and nucRNA
coverage at annotated genes. C) nucRNA to RNAPII coverage ratio for
the promoter (pr), 39 end (39) and double RNAPII peak (pr/39) categories
as well as at genes with low stalling indices at both ends (no).
doi:10.1371/journal.pone.0049274.g005
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not nucRNA in erythroid cells. To delineate these regions we
identified peaks in RNAPII binding using the SISSRs (Site
Identification from Short Sequence Reads) algorithm which was
originally designed to identify transcription factor binding sites
[65]. From the resulting 3118 RNAPII+ peaks we removed those
found to overlap with regions of nucRNA coverage (maximum gap
width 100 bp; minimum size 1000 bp, identified in SeqMonk,
[66]), thereby excluding those peaks in RNAPII binding that were
associated with moderate to abundant transcription. This
narrowed our original candidate list to 1598 RNAPII+/nucRNA-
regions (Table S5). 25.9% of these overlap a TSS (+/2500 bp),
24.9% are found within a gene body, a further 5.3% and 11.4%
are positioned within 10 kb upstream and downstream of a gene,
respectively. The remaining 32.5% are located in intergenic
Figure 6. RNAPII is associated with enhancer regions. A) The Hbb (b-globin) LCR, located upstream of the Hbb genes, contains six characterized
erythroid-specific DNase I hypersensitive sites (HS1-6). Peaks of RNAPII (green) identified using SISSRs overlapped HS1-4. Erythroid-expressed
transcription factors have also been found associated with the LCR, overlapping the HS and RNAPII peaks. RNAPII ChIP sequences are shown in green,
genomic DNA input sequences are shown in black and nucRNA sequences (only three in this region) are shown in blue. B) Distribution of RNAPII+/
nucRNA- peaks relative to annotated genes. Roughly half of the RNAPII peaks identified by SISSRs are located in intergenic regions with 32.5% located
more than 10 kb from an annotated gene (intergenic). C) Overlap of RNAPII+/nucRNA- peaks with erythroid-expressed transcription factors and
conserved regions. D) An RNAPII+/nucRNA- peak 77 kb upstream of the Lmo2 gene overlaps TF binding sites and is homologous to a validated
enhancer identified in the human genome. Enhancer homology regions are indicated by black boxes joined by a line to delineate the human
enhancer construct used in the generation of transgenic mice. NucRNA and RNAPII peaks surrounding the Lmo2 gene are shown in blue and green
respectively.
doi:10.1371/journal.pone.0049274.g006
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regions, more than 10 kb away from the nearest annotated gene
(at a mean distance of 0.4 Mbp from the nearest transcribed gene,
defined by overlap with a nucRNA enriched region, Figure 6B).
We next investigated these RNAPII+/nucRNA- regions for
additional features associated with regulatory regions. To this end,
we examined the evolutionary sequence conservation around our
candidates, which has been shown to improve identification of
regulatory modules [67,68]. In several studies, intergenic sequenc-
es with high evolutionary sequence conservation have been found
to have enhancer activity in the developing embryo [69], to
demarcate the regulatory elements of the human HBB locus [70],
and to identify regulatory motifs on a genome-wide scale [71,72],
supporting the idea that these regions have regulatory potential.
We calculated the proportion of PhastCons [73] conservation
scores greater than 0.8 in the 1 kb sequence surrounding RNAPII
peak midpoints and found significantly higher conservation at
RNAPII+/nucRNA- regions compared to random regions (Log
Odds ratio = 0.19, p,0.01).
Regulatory potential has been shown to be best predicted when
sequence conservation information is integrated with transcription
factor binding information [68,74,75]. As further validation that
the RNAPII+/nucRNA- regions represented regulatory elements,
we retrieved transcription factor (TF) ChIP-Seq datasets for mouse
erythroid cells and compared RNAPII+/nucRNA- peaks to
regions associated with the transcription factors GATA1, KLF1,
LDB1, TAL1, ETO2 and MTGR1 (summarised in Table S6;
[35,62,63]). After alignment, we identified TF binding peaks using
the SISSRs algorithm [65], and found RNAPII+/nucRNA- peaks
significantly overlapped transcription factor binding sites (for all
TFs combined, Log Odds ratio = 3.04, p,0.0001, Table S7,
Figure 6C). In addition to finding enrichment in individual TF
binding sites within our putative regulatory elements, we also
found that several RNAPII+/nucRNA- regions were bound by
multiple TFs. Restricting our candidate list to an ‘erythroid subset’
(138 regions) which overlapped erythroid-expressed TFs improved
the observed sequence conservation in those regions (Log Odds
ratio = 1.48, p,1.8E-08) which likely indicates regulatory func-
tion. Some notable examples include the TF-bound HS of the Hbb
LCR, a TF-bound validated enhancer upstream of the Lmo2 gene
[76] as well as TF-bound regions upstream of the Pim1 and Klf3
genes (Figure 6D and Figure S10). We also found significant
overlap with p300 (Log Odds ratio = 1.6006, p,0.0001) EN-
CODE ChIP-Seq peaks identified in MEL cells (Tables S6 and S7)
[2]. Peaks of the histone acetyl transferase p300 have been shown
to predict regions with enhancer function in other tissues
[77,78,79].
A large proportion of our RNAPII+/nucRNA- peaks do not
overlap with TF binding sites identified through the transcription
factor ChIP-Seq data for mouse erythroid cells, suggesting that the
current suite of data may not represent all the TFs important in
regulating gene expression in erythroid cells. We sought to
investigate the possibility that the remaining candidates may still
identify TF-bound regulatory regions by conducting a supervised
motif search within these regions using JASPAR [80] TF binding
profiles and the Clover algorithm [81]. To validate our approach,
we first confirmed that the expected motifs were identified in silico
in the ‘erythroid subset’ of RNAPII+/nucRNA- peaks known to
bind erythroid-expressed TFs based on the ChIP-Seq data
available (Table S7). We did identify enrichment in the motifs
for TAL1/GATA1 (raw Clover score 31.9, p,0.001), both of
which are TFs in the ‘erythroid subset’ (Table S8). We also
identified motifs for KLF4 (Clover 40.8, p,0.001) and NFYA
(Clover 7.69, p = 0.001), both known to regulate gene expression
in erythroid cells [82,83]. As the binding matrix for KLF1 (not
contained in the Jaspar database) is highly similar to the binding
matrix for KLF4 [63] and KLF4 expression is lower (nucRNA 1.0
fold enriched over input) than that of KLF1 (nucRNA 4.5 fold
enriched over input) it is likely that enrichment of KLF4 motifs
represents sequences predominantly bound by KLF1 in erythroid
cells. The remaining RNAPII+/nucRNA- peaks contained profiles
for a number of erythroid-expressed TFs including SPI1 [84]
(Clover 133.0, p,0.001) and ETS1 [85] (Clover 26.8, p,0.001)
(Table S9). This inferred TF binding potential further demon-
strates the efficacy of using RNAPII binding to identify potential
regulatory regions [57].
This approach allowed us to infer the involvement of TFs for
which ChIP-Seq data is not available, and showed that RNAPII+/
nucRNA- peaks identify regions under selective pressure contain-
ing binding sites for multiple cell type-specific and basal TFs.
NucRNA-Seq identifies stable, nuclear-retained long non-
coding RNAs
In addition to the RNAPII-associated intergenic regions we also
noticed that a number of intergenic regions are transcribed above
background levels. Many of these transcribed intergenic regions
appeared to be several kilobases in size, potentially representing
long non-coding RNAs (lncRNAs). lncRNAs are emerging as
mediators in the regulation of genome function, alongside and in
combination with epigenetic and transcription factor-based
mechanisms [86,87,88,89]. Many lncRNAs appear to regulate
gene expression, primarily at the level of transcription (e.g. Air or
Xist) [31,87,88,90,91]. We hypothesised that a class of stable
nuclear-retained RNAs could be identified from the nucRNA-Seq
data as intergenic transcription units with promoters bound by
relevant transcription factors.
To obtain as large an initial candidate cohort as possible, we
used the ‘Contig Probe Generator’ feature of SeqMonk [66], to
identify clusters of nucRNA-Seq reads in an unbiased manner. By
inspection, highly expressed genes were best identified allowing for
a maximum 2 kb gap size between nucRNA-Seq reads and
excluding candidates below 4.5 kb. Applying these conditions to
our data, we identified 6,429 semi-contiguous regions of RNA
coverage which did not overlap annotated genes (from an initial
list of 24,396). We observed that low expressed genes were better
identified with a different parameter set (1 kb gap size, 2.5 kb
minimum candidate size, and merging candidates separated by
less than 5 kb), which when applied to our data identified a further
1,154 candidates, yielding a final list of 7,583 candidate regions.
This initial list excluded regions which overlapped annotated
coding regions, pseudogenes, ribosomal RNAs and micro RNAs.
We hypothesised that at least a subset of the candidates could
represent stable, nuclear retained RNA species. We therefore
refined the candidate list to focus on stable lncRNAs by identifying
candidates with relatively high levels of nucRNA-Seq coverage
compared to RNAPII ChIP-Seq coverage. These candidates
would therefore be part of the intergenic ‘‘T’’ subset discussed
earlier. Candidate coverage was quantified as the average
coverage depth, normalized for candidate length and total number
of reads; 305 candidates with a higher nucRNA-Seq to RNAPII
ChIP-Seq coverage ratio were selected (Table S10). From these
305 candidates, 72 (23.6%) overlapped RefSeq annotated ncRNA
features including Malat1, 5830416P10Rik, A130040M12Rik,
Gm1995 and Neat1, 17 (5.5%) overlapped lncRNAs identified by
Guttman et al. 2009 and 36 (12%) overlapped erythroid expressed
lncRNA identified by Hu et al. 2011 [92,93]. Interestingly, our
candidates often consolidated a cluster of previously identified
lncRNAs into a larger transcript, for example the Neat1 transcript
(lncRNA2, Figure S11) [92].
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We selected 12 candidates showing a variety of expression levels
for further validation (Table S11). We first characterized these 12
candidate lncRNAs in terms of their nuclear confinement using
RT-qPCR on nuclear and cytoplasmic RNA fractions. All 12
candidate tested were found to have a preferred nuclear
localisation (Figure 7A). We then assessed the RNA stability of
the 12 RNAs by qRT-PCR following Actinomycin D treatment to
inhibit nascent transcription. All 12 proved to be more stable than
the Myc primary transcript (Figure 7B) and several of the
candidates showed transcript stability similar to Air. Lastly, strand
prediction was done by comparing patterns of H3K4Me3 and
H3K36Me3 histone modifications which are thought to identify
promoter and gene body regions of transcription units, respec-
tively. Data derived from ES cells was used [56] so not all
candidates could be annotated (Table S11). Strand prediction
based on histone modifications was confirmed by RNA FISH in all
candidates. Furthermore, RNA FISH revealed a distribution into
distinct nuclear foci (selected images shown in Figure 7C–F).
Candidate 1, which is by far the most highly expressed of all the
candidates, corresponds to Malat1 and was found distributed in
multiple nuclear foci. Malat1 (Metastasis associated lung adenocarcinoma
transcript 1) is a lncRNA shown to be a post-transcriptional
regulator of transcription in synaptogenesis [89,94], though the
high level of expression in erythroid cells suggests a wider role for
this stable nuclear-retained lncRNA.
Discussion
The recent explosion in the number of genome-wide datasets
has greatly increased our appreciation of transcriptome complexity
and regulation, particularly the role of polymerase distribution,
intergenic regulatory elements and non-coding RNAs. Here we
study transcriptional output in erythroid cells by sequencing
nuclear RNA and chromatin bound by active RNA polymerase II.
We show that nucRNA-Seq identifies mainly unspliced primary
transcripts and is significantly different than poly(A)-enriched
RNA-Seq. Then, we investigated the relationship between
RNAPII occupancy and nucRNA output, identified intergenic
regions of the genome associated with RNAPII which have
characteristics of regulatory regions and identified novel, stable,
nuclear-retained lncRNAs expressed in adult erythroid cells.
Our observations show that a generalized level of RNAPII
occupancy is a poor predictor of expression levels for most
transcription units, with only very highly expressed RNAPII-
transcribed genes showing a correlation between RNAPII
association and transcriptional output. These results suggest that
polymerase occupancy is just one of potentially many factors
influencing the level of transcription of chromatin templates. Peaks
of RNAPII found in promoter-proximal regions have been
suggested to represent paused polymerase and correlate with
lower expression [6,8]. Our analysis confirmed these observations
in that RNAPII peaks at the 59 end of genes generally correlated
with lower expression of the genes. Furthermore, our results show
that genes displaying RNAPII peaks at their 39 ends are also
poorly expressed. We also observed genes with RNAPII peaks
within the gene body suggesting that other pause sites exist which
may impede transcription. It remains to be determined whether or
not these 39 and internal RNAPII peaks actually represent
engaged, paused polymerase. In accordance with these sites as
polymerase pausing locations a study in S. cerevisiae, identifying the
39 ends of nascent transcripts, using the NET-Seq (native
elongating transcript sequencing) technique, identified numerous
pause sites within genes [95].
We also found that accumulation of polymerase at the 59 end of
genes is not always associated with lower expression. In particular,
genes featuring both 59 and 39 RNAPII peaks are more efficiently
transcribed than genes with either peak alone. These peaks of
RNAPII located within both the 59 and 39 regions of the ‘‘double
RNAPII peak’’ genes may reflect a point of chromatin-chromatin
interaction between these two regions allowing both locations to
be captured in the RNAPII pull-down. Gene loop interactions
between the promoter and 39 end of inducible genes in S. cerevisiae
have been associated with more rapid induction of transcription
[96]. Our results indicating that genes displaying both 59 and 39
peaks of RNAPII are more efficiently transcribed suggest that
similar gene loop interactions could occur at selected genes in
higher eukaryotes and that these interactions contribute to
increased gene expression.
Long range chromatin interactions are known to occur between
regulatory regions and active genes [17,19–27]. Our RNAPII
ChIP-seq data identified intergenic regions bound by RNAPII,
erythroid cell-expressed TFs and p300. This approach not only
reveals regulatory regions by virtue of their TF binding properties,
but potentially identifies the subset of regulatory regions physically
associated with transcribing genes and as a result immunoprecip-
Figure 7. Transcribed intergenic regions correspond to long
non-coding RNAs. A) Nuclear vs cytoplasmic distribution for lncRNA
candidates determined by RT-qPCR. B) Stability of nuclear retained
lncRNA candidates was assessed by treatment with ActD for 1 and
4 hrs. Transcript levels were determined by RT-qPCR. Intranuclear
distribution of lncRNA candidates was determined by RNA FISH for: C)
lncRNA1 (Malat1), D) lncRNA2 (Neat1), E) lncRNA9, and F) lncRNA11,
scale bar = 2 mm.
doi:10.1371/journal.pone.0049274.g007
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itated with the anti-RNAPII antibody. In agreement with this
possibility, a subset of neuronal enhancers are bound by RNAPII
[58]. However, in contrast to the neuronal study, we failed to
detect enhancer-associated RNAs [58] in our dataset. We presume
that these RNAs may not have been captured in our library
preparation due to their size, stability or abundance. It has been
shown that HS2 of the human HBB LCR has promoter activity
and the entire LCR region is transcribed [97,98,99,100,101]. It is
likely that the mouse LCR has similar properties and yet we did
not identify significant levels of nucRNA in this region by
nucRNA-Seq suggesting these transcripts are of relatively low
abundance compared with the rest of the nuclear transcriptome. It
should be noted that we cannot distinguish whether RNAPII is
present at these regulatory regions as a result of their close
association with the highly active Hbb gene, synthesis of short-lived
LCR ncRNA, or both. A previous study has identified LCR
transcripts and shown that RNAPII is present at the LCR in
mouse embryonic stem cells which do not express any of the Hbb
genes suggesting the LCR recruits RNAPII independently of and
prior to Hbb gene transcription [102].
In sequencing the nuclear RNA pool we were able to identify
stable, nuclear-retained lncRNAs. These RNA species were found
to be enriched in the nuclear fraction and many are present at low
levels. They are likely to be missed in approaches that isolate total
RNA as the cytoplasmic RNA pool is larger than the nuclear RNA
pool. In comparing to existing sets of lncRNAs identified from
total RNA we found only limited overlap with our set indicating
that by isolating the nuclear pool of RNA we were able to identify
novel nuclear retained transcripts that are masked by the
cytoplasmic pool in other RNA-Seq studies. In support of this
we found that for the 12 candidates we investigated further these
RNAs were found almost exclusively in the nuclear fraction. One
point of note is that in this approach, purely because we exclude
candidates which overlap annotated genes, we overlook antisense
and gene-overlapping lncRNAs. By inspection, such RNAs are still
immediately obvious, the Kcnq1ot1 transcript being one example
(Figure S12). Future experiments using strand-specific methodol-
ogies will help further annotate this part of the nuclear
transcriptome [103,104]. The nuclear-retained non-coding tran-
scripts we identified are relatively stable and show lower
association with RNAPII compared to other protein-coding genes
expressed at similar levels (they are in the T sub-group). This
suggests that they would be less easily identified using genome-
wide techniques that identify nascent transcripts such as the GRO-
Seq, NET-Seq and genome-wide nuclear run-on assays
[9,95,105].
The accurate and thorough characterization of transcriptional
output represents an important step in the understanding of the
regulatory environment in which gene expression occurs for a
particular cell type or induced state [106]. Sequencing the nuclear
transcriptome reveals the relative levels of primary transcripts and
in addition identifies novel nuclear retained lncRNAs not
identified from total RNA-Seq studies. In this study we have
presented a detailed description of the nuclear transcriptome in
erythroid cells, though the methods described here could be
applied to any given cell type or state including disease,
experimentally perturbed states and cell fate changes.
Methods
Tissue collection
We collected spleens of anemic mice (C57BL/6) 5 days after
treating them with phenylhydrazine [107]. The 5 day anemic
spleen was found to be composed of .85% globin-expressing
erythroid cells [40]. We disrupted fresh spleen tissue into a single-
cell suspension in ice-cold phosphate-buffered saline and processed
cells immediately as detailed below. All animal experimental
procedures were carried out under a project license granted from
the Home Office, UK.
RNAPII ChIP-Seq
RNAPII ChIP was carried out as described in Mitchell and
Fraser 2008 [59]. Genome-wide RNAPII association was deter-
mined by sequencing libraries constructed from the RNAPII-S5P
chromatin immunopurified (using Ab5131, Abcam) and genomic
input material.
nucRNA-Seq
Genome-wide transcriptional output was characterized by
sequencing a double-stranded cDNA library constructed from
nuclear RNA (nucRNA). Following a hyper-osmotic swell in
10 mM Tris-HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.1 M
sucrose, 0.1% Triton X-100 and 0.5 mM DTT, a single cell
suspension was homogenised with a B-type Dounce. Intact nuclei
were then separated from cytoplasmic debris through a 5 mM
MgCl2, 10 mM Tris pH 8.0, 0.5 mM DTT, 0.33 M sucrose
cushion at 300 g and re-suspended in 10 mM Tris-HCl pH 7.5,
10 mM NaCl, 3 mM MgCl2. RNA was purified from nuclear and
cytoplasmic fractions using Trizol LS (Invitrogen) according to the
supplier’s instructions. Purified RNA was treated with 10 U of
DNaseI (Roche) for 20 min at 28uC. RNA quality was verified on
a Bioanalyzer (Agilent). Reverse transcription was performed using
Superscript II (Invitrogen) and 10 mg random hexamer primers
(Roche) per 500 ng RNA. Second strand synthesis was performed
using E. coli RNase H (Ambion) and E. coli DNA Polymerase I
(NEB) as described in Sambrook and Russell 2001 [108].
Sequencing and Data Analysis
Library preparation was performed according to Illumina PE
genomic protocol, incorporating improvements suggested in Quail
et al 2008, with all reactions scaled according to starting DNA
quantity [109,110]. Using the Illumina GA-IIx platform, we
sequenced paired-end 36 bp reads from the generated libraries.
Sequencing data was submitted to the Sequence Read Archive
(SRA, http://www.ebi.ac.uk/ena/data/view/ERP000702). Se-
quences were aligned using Bowtie [111], by suppressing
alignments to only 1 best reportable alignment with a maximum
number of 2 mismatches within 28 nucleotides of seed length in
the high quality end. A gap width of 2500 bp was allowed between
paired end reads. When comparing to G1E and G1E-ER4+E2
RNA-Seq data all reads were mapped as single end reads using the
indicated Bowtie settings. Sequences were visualised using
SeqMonk [66] and the UCSC genome browser. We used the
mouse Ensembl gene annotations throughout (genome version
NCBIM37). Genes smaller than 300 bp were excluded from the
list of genes investigated in the RNAPII stalling section. Peaks were
identified using SISSRs (p,0.001) [65] and SeqMonk [66]. Perl,
Java and R were used for further data processing. SPSS (version
18) was used for statistical analysis as detailed in the text.
Transcript stability assay
Tissue was obtained and disrupted as described above, cultured
for 1 or 4 hours in Dulbecco’s Modified Eagle Medium (Gibco)
supplemented with 10% fetal bovine serum and 10 mg/ml
Actinomycin D (Sigma) with gentle mixing. Nuclear RNA and
cDNA were prepared as detailed above. This cDNA was then used
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to assess the transcript stability in the absence of active
transcription (primer sequences listed in Table S12).
Real-time PCR
All RT-qPCR was carried out using SYBR Green on an ABI
7000 detection system (both Applied Biosystems). Primer sequenc-
es listed in Table S12.
RNA FISH
RNA FISH was carried out as detailed in [112]. Probes were
designed against intronic regions to detect primary transcripts.
Expression was calculated as the percentage of alleles with a
detectable signal in a cell population taken from randomly selected
fields of view. Multiple probes were designed against candidate
lncRNAs and were detected as for intronic probes.
Supporting Information
Figure S1 Reproducibility of nucRNA-Seq coverage.
RPKM values of nucRNA-Seq coverage in three biological
replicate nucRNA-Seq libraries (F1.2, F2.2 and F3.2) are highly
correlated (Spearman’s rho .0.8, p,0.0001). Scales represent
log2 RPKM values taken for Ensembl genes (genome version
NCBIM37), *** indicates p,0.0001, correlation coefficients
represent Spearman’s rho.
(PDF)
Figure S2 RT-qPCR Validation of nucRNA-Seq coverage
for 48 amplicons. Observed coverage in our sequence data for
48 randomly selected nucRNA-enriched regions was validated.
For these regions, we assayed RNA levels by RT-qPCR in two
independent nuclear RNA preparations. We observed a significant
association between both the maximum nucRNA-Seq coverage
depth (Spearman’s rho (rs) = 0.761, 95% CI [0.608, 0.859],
p,0.01) and average coverage depth (rs = 0.781, 95% CI [0.638,
0.871], p,0.01).
(PDF)
Figure S3 Normalising data coverage to input genomic
DNA coverage. A) A SeqMonk screenshot of a 0.5 Mb region
around the Hjurp locus is depicted. Each track contains individual
reads (small blue and red marks) and bars representing quantitated
average coverage depth, non-normalised to input levels, for a 5 kb
sliding window (1 kb step size). False positive enrichment of both
nucRNA-Seq and RNAPII ChIP-Seq coverage can be observed
around the Hjurp locus, in the area where input coverage is
abnormally high. The need for normalisation is demonstrated by
the fact that while clearly the Hjurp gene (centre, blue) is RNAPII
bound and transcribed, it is not bound or transcribed at the levels
indicated by non-normalised measures of coverage. (B and C)
Shows a comparison of non-normalised RNAPII ChIP-Seq (B)
and nucRNA-Seq (C) average coverage depth against the average
input gDNA coverage depth for all annotated genes (NCBIM37),
the middle panel shows a histogram of average coverage depth for
annotated genes. The right histogram shows the same coverage
normalised to the corresponding input value (fold enrichment over
input).
(PDF)
Figure S4 Nuclear RNA-Seq data compared to RNA-Seq
data. RPKM values for exon 1 were compared between erythroid
nucRNA-Seq and two erythroid RNA-Seq (G1E and
G1e_ER4_E2). The two RNA-Seq libraries are highly correlated
(Spearman’s rho 0.88) while the nucRNA-Seq library is less well
correlated (Spearman’s rho 0.25 and 0.30). Scales represent log2
RPKM values taken for Ensembl genes (genome version
NCBIM37), *** indicates p,0.0001.
(PDF)
Figure S5 Real-time PCR validation of RNAPII ChIP
material. Fold enrichment relative to input was determined for
specific gene regions by real-time PCR. We detected reproducibly
high levels of enrichment at erythroid-expressed genes (Hba, Hbb,
Slc4a1, and Hmbs) while non-expressed genes (Nefm and VH16) were
not enriched above background binding relative to the IgG control
material or in relation to the input material. Error bars represent
SEM calculated for 3 technical replicates.
(PDF)
Figure S6 Nuclear RNA and RNAPII ChIP sequencing
tag density at erythroid-expressed genes. Sequence
coverage at the A) Hba and B) Slc4a1 genes.
(PDF)
Figure S7 Validation of RNAPII ChIP-Seq coverage for
48 amplicons. Observed coverage in our sequence data was
validated for the same 48 randomly selected nucRNA-enriched
regions used in Figure S3. For these regions, we assayed fold ChIP
enrichment over input by qPCR in three independent RNAPII
ChIP experiments. We observed a significant association between
the fold enrichment assessed by qPCR and the RNAPII ChIP-Seq
data, both for maximum coverage depth in the tested amplicon
(rs = 0.683, 95% CI [0.489, 0.812], p,0.01) and for average
coverage depth (rs = 0.668, 95% CI [0.477, 0.799], p,0.01).
(PDF)
Figure S8 Stalling categories. We compared promoter
proximal and terminator proximal stalling, identifying 300 genes
with promoter stalling, 300 genes with terminator (39 end) stalling
and 60 genes with both promoter and terminator (39 end) stalling
(thresholds set at the 95th percentile for each category).
(PDF)
Figure S9 RNAPII ChIP-Seq coverage at genes in the
promoter-proximal, 39 end and double RNAPII peak
categories. A) Calm1 displays a promoter-proximal RNAPII
peak, B) Sec14l2 displays a 39 end RNAPII peak, C) Pttg1ip displays
an RNAPII peak in both the promoter-proximal and 39end region.
Sequenced tags are depicted in black, fold enrichment over input
in the promoter-proximal region (+/2300 bp), 39 end (+/
2300 bp) and gene body is shown by grey boxes with numbers
indicating the fold enrichment value in each region. Image
exported from SeqMonk.
(PDF)
Figure S10 Putative regulatory regions upstream of
erythroid expressed genes. A) Two intergenic RNAPII peaks
upstream of the Pim1 gene overlap several TF binding sites. B)
One RNAPII peak upstream of the Klf3 gene overlaps several TF
binding sites.
(TIF)
Figure S11 Stable ncRNA candidates expressed in
erythroid cells. Mouse chr19 is depicted from 5758468–
5875817 (117 kbp) with annotated coding mRNA shown in red
(forward) and blue (reverse) depending on the transcript direction.
Candidate ncRNAs identified by Guttman et al 2009 are indicated
by dark grey boxes. Candidate ncRNAs identified in our study are
indicated by light grey boxes. NucRNA sequences are depicted
below the ncRNA candidates. Image exported from SeqMonk.
(TIF)
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Figure S12 The Kcnq1ot1 ncRNA is detected by nucRNA-
Seq. Mouse chr7 is depicted from 150293116–150612579
(319.46 kbp). Kcnq1 transcripts are depicted with the nucRNA
sequences mapped to this region depicted below. The region of
increased nucRNA levels corresponds to the antisense Kcnq1ot1
trasncript. Image exported from SeqMonk.
(TIF)
Table S1 Number of reads per kilobase of gene length
per million mapped reads (RPKM) in nucRNA-Seq
replicates.
(XLSX)
Table S2 Transcription frequency determined by RNA
FISH.
(DOC)
Table S3 Gene Ontology term enrichments for B, T and
BT gene classes.
(XLSX)
Table S4 RNAPII binding patters, promoter peak,
terminator peak and double peaks.
(XLSX)
Table S5 RNAPII+/nucRNA- peaks.
(XLSX)
Table S6 Transcription factor ChIP-Seq data used.
(DOC)
Table S7 Overlap between ChIP-Seq peaks. Using 1 kb
bins across the genome overlapping regions of RNAPII+/
nucRNA- and all erythroid transcription factors (TFs) or p300
were investigated. Log odds ratios and P values were calculated for
peaks in each of the indicated regions of the genome.
(DOC)
Table S8 Validation of supervised motif analysis;
indentified motifs for RNAPII+/nucRNA- candidates
overlapped by TF binding sites identified through
publicly available ChIP-Seq data.
(DOC)
Table S9 Supervised motif analysis for RNAPII+/
nucRNA- candidates not overlapped by TF binding sites
identified through publicly available ChIP-Seq data.
(DOC)
Table S10 Predicted ncRNA candidates.
(XLSX)
Table S11 Selected long ncRNA candidate regions.
(DOC)
Table S12 RNAPII ChIP-seq and nuRNA-seq validation
primers.
(DOC)
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